Cargando…

Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder

OBJECTIVE: We previously reported an association between dysbindin gene (DTNBP1) variants and bipolar I disorder (BID). This paper expands upon previous findings suggesting that DTNBP1 variants may play a role in the response to acute mood stabilizer treatment. METHODS: A total of 45 BID patients we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Dong-Hwan, Pae, Chi-Un, Drago, Antonio, Mandelli, Laura, De Ronchi, Diana, Patkar, Ashwin A., Paik, In Ho, Serretti, Alessandro, Kim, Jung-Jin
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796018/ https://www.ncbi.nlm.nih.gov/pubmed/20046352 http://dx.doi.org/10.4306/pi.2008.5.2.102

Ejemplares similares

Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder
por: Porcelli, Stefano, et al.
Publicado: (2014)

PM449. Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples
por: Porcelli, Stefano, et al.
Publicado: (2016)

Can Antipsychotic Agents be Considered as Real Antimanic Treatments?
por: Bourin, Michel, et al.
Publicado: (2014)

Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
por: Calabrò, Marco, et al.
Publicado: (2018)

Audit of Antimanic Agents Monitoring in a High Secure Hospital
por: Oluwaranti, Oluwaseun, et al.
Publicado: (2023)

CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients
por: Drago, Antonio, et al.
Publicado: (2015)

The Influence of AHI1 Variants on the Diagnosis and Treatment Outcome in Schizophrenia
por: Porcelli, Stefano, et al.
Publicado: (2015)

Preclinical Evidences for an Antimanic Effect of Carvedilol
por: de Souza, Greicy Coelho, et al.
Publicado: (2015)

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2018)

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2020)

Epistatic Interactions between CREB and CREM Variants in Affective Disorder
por: Chiesa, Alberto, et al.
Publicado: (2014)

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway
por: Cocchi, Enrico, et al.
Publicado: (2016)

Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1
por: Calabrò, Marco, et al.
Publicado: (2019)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders
por: Crisafulli, Concetta, et al.
Publicado: (2021)

Incomplete Coverage of Candidate Genes: A Poorly Considered Bias
por: Drago, Antonio, et al.
Publicado: (2007)

Pharmacogenetics of antidepressant response: An update
por: Drago, Antonio, et al.
Publicado: (2009)

Triple Reuptake Inhibitors: The Next Generation of Antidepressants
por: Marks, David M, et al.
Publicado: (2008)

Triple Reuptake Inhibitors: A Premise and Promise
por: Marks, David M., et al.
Publicado: (2008)

Strategies to Find Candidate Genes for Bipolar Disorder
por: Pae, Chi-Un
Publicado: (2009)

Antimanic Efficacy, Tolerability, and Acceptability of Clonazepam: A Systematic Review and Meta-Analysis
por: Lappas, Andreas S., et al.
Publicado: (2023)

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia
por: Jun, Rachel, et al.
Publicado: (2022)

Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective
por: Marks, David M., et al.
Publicado: (2009)

ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
por: Calabrò, Marco, et al.
Publicado: (2020)

Dysbindin-1 Involvement in the Etiology of Schizophrenia
por: Wang, Haitao, et al.
Publicado: (2017)

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions
por: Gao, Yonglin, et al.
Publicado: (2015)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

TRIM32 is an E3 ubiquitin ligase for dysbindin
por: Locke, Matthew, et al.
Publicado: (2009)

Dysbindin-1 genotype effects on emotional working memory
por: Wolf, Claudia, et al.
Publicado: (2009)

Behavioral characterization of mice overexpressing human dysbindin-1
por: Shintani, Norihito, et al.
Publicado: (2014)

Dysbindin-1 regulates mitochondrial fission and gamma oscillations
por: Zhao, Jun, et al.
Publicado: (2021)

Dysbindin-Associated Proteome in the P2 Synaptosome Fraction of Mouse Brain
por: Han, Meng-Hsuan J., et al.
Publicado: (2014)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
por: Wang, Sheng-Min, et al.
Publicado: (2014)

Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action
por: Wang, Sheng-Min, et al.
Publicado: (2015)

Vilazodone for the Treatment of Depression: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2021)

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
por: Pae, Chi-Un, et al.
Publicado: (2021)

Chronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscaling
por: Gideons, Erinn S, et al.
Publicado: (2017)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pvkq6eva0fpfgrk86qj040ksk0